The DOI matches its Crossref record; 128 of the 128 references it cites were found in a registry or an index.
The disparate origins of ovarian cancers: pathogenesis and prevention strategies
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
ARID1A Mutations in Endometriosis-Associated Ovarian Carcinomas
Wiegand, K. C., Shah, S. P., Al-Agha, O. M., Zhao, Y., Tse, K., Zeng, T., Senz, J., McConechy, M. K., Anglesio, M. S., Kalloger, S. E., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1008433 · Cited by 1,712
Self-citationEskenazi, B., & Warner, M. L. (1997) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/s0889-8545(05)70302-8 · Cited by 1,617
Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer
Versteege, I., Sévenet, N., Lange, J., Rousseau-Merck, M.-F., Ambros, P., Handgretinger, R., Aurias, A., & Delattre, O. (1998) · Nature · doi:10.1038/28212 · Cited by 1,556
Frequent Mutations of Chromatin Remodeling Gene ARID1A in Ovarian Clear Cell Carcinoma
Jones, S., Wang, T.-L., Shih, I.-M., Mao, T.-L., Nakayama, K., Roden, R., Glas, R., Slamon, D., Diaz, L. A., Vogelstein, B., et al. (2010) · Science · doi:10.1126/science.1196333 · Cited by 1,219
INCESSANT OVULATION—A FACTOR IN OVARIAN NEOPLASIA ?
Fathalla, M. F. (1971) · The Lancet · doi:10.1016/s0140-6736(71)92335-x · Cited by 1,119
Kindelberger, D. W., Lee, Y., Miron, A., Hirsch, M. S., Feltmate, C., Medeiros, F., Callahan, M. J., Garner, E. O., Gordon, R. W., Birch, C., et al. (2007) · The American Journal of Surgical Pathology · doi:10.1097/01.pas.0000213335.40358.47 · Cited by 1,113
Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer—Shifting the paradigm
Kurman, R. J., & Shih, I.-M. (2011) · Human Pathology · doi:10.1016/j.humpath.2011.03.003 · Cited by 1,073
Jacobs, I. J., Menon, U., Ryan, A., Gentry-Maharaj, A., Burnell, M., Kalsi, J. K., Amso, N. N., Apostolidou, S., Benjamin, E., Cruickshank, D., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(15)01224-6 · Cited by 1,048
Crisponi, L., Deiana, M., Loi, A., Chiappe, F., Uda, M., Amati, P., Bisceglia, L., Zelante, L., Nagaraja, R., Porcu, S., et al. (2001) · Nature Genetics · doi:10.1038/84781 · Cited by 990
Somatic Sex Reprogramming of Adult Ovaries to Testes by FOXL2 Ablation
Uhlenhaut, N. H., Jakob, S., Anlag, K., Eisenberger, T., Sekido, R., Kress, J., Treier, A.-C., Klugmann, C., Klasen, C., Holter, N. I., et al. (2009) · Cell · doi:10.1016/j.cell.2009.11.021 · Cited by 962
Pearce, C. L., Templeman, C., Rossing, M. A., Lee, A., Near, A. M., Webb, P. M., Nagle, C. M., Doherty, J. A., Cushing-Haugen, K. L., Wicklund, K. G., et al. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70404-1 · Cited by 939
Self-citationMedeiros, F., Muto, M. G., Lee, Y., Elvin, J. A., Callahan, M. J., Feltmate, C., Garber, J. E., Cramer, D. W., & Crum, C. P. (2006) · American Journal of Surgical Pathology · doi:10.1097/01.pas.0000180854.28831.77 · Cited by 916
A candidate precursor to serous carcinoma that originates in the distal fallopian tube
Lee, Y., Miron, A., Drapkin, R., Nucci, M., Medeiros, F., Saleemuddin, A., Garber, J., Birch, C., Mou, H., Gordon, R., et al. (2007) · The Journal of Pathology · doi:10.1002/path.2091 · Cited by 898
Collaborative Group on Epidemiological Studies of Ovarian Cancer (2008) · The Lancet · doi:10.1016/s0140-6736(08)60167-1 · Cited by 822
Piek, J. M. J., van Diest, P. J., Zweemer, R. P., Jansen, J. W., Poort‐Keesom, R. J. J., Menko, F. H., Gille, J. J. P., Jongsma, A. P. M., Pals, G., Kenemans, P., et al. (2001) · The Journal of Pathology · doi:10.1002/path.1000 · Cited by 787
Mutation of FOXL2 in Granulosa-Cell Tumors of the Ovary
Shah, S. P., Köbel, M., Senz, J., Morin, R. D., Clarke, B. A., Wiegand, K. C., Leung, G., Zayed, A., Mehl, E., Kalloger, S. E., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0902542 · Cited by 768
Self-citationSchmidt, D., Ovitt, C. E., Anlag, K., Fehsenfeld, S., Gredsted, L., Treier, A.-C., & Treier, M. (2004) · Development · doi:10.1242/dev.00969 · Cited by 762
Oral Contraceptives and the Risk of Hereditary Ovarian Cancer
Narod, S. A., Risch, H., Moslehi, R., Dørum, A., Neuhausen, S., Olsson, H., Provencher, D., Radice, P., Evans, G., Bishop, S., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199808133390702 · Cited by 615
Perets, R., Wyant, G. A., Muto, K. W., Bijron, J. G., Poole, B. B., Chin, K. T., Chen, J. Y. H., Ohman, A. W., Stepule, C. D., Kwak, S., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.10.013 · Cited by 596
Foxl2 disruption causes mouse ovarian failure by pervasive blockage of follicle development
Uda, M., Ottolenghi, C., Crisponi, L., Garcia, J. E., Deiana, M., Kimber, W., Forabosco, A., Cao, A., Schlessinger, D., & Pilia, G. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh124 · Cited by 583
The ovary: basic biology and clinical implications
Richards, J. S., & Pangas, S. A. (2010) · Journal of Clinical Investigation · doi:10.1172/jci41350 · Cited by 561
One tissue, two fates: molecular genetic events that underlie testis versus ovary development
Brennan, J., & Capel, B. (2004) · Nature Reviews Genetics · doi:10.1038/nrg1381 · Cited by 549
Yemelyanova, A., Vang, R., Kshirsagar, M., Lu, D., Marks, M. A., Shih, I. M., & Kurman, R. J. (2011) · Modern Pathology · doi:10.1038/modpathol.2011.85 · Cited by 513
Witkowski, L., Carrot-Zhang, J., Albrecht, S., Fahiminiya, S., Hamel, N., Tomiak, E., Grynspan, D., Saloustros, E., Nadaf, J., Rivera, B., et al. (2014) · Nature Genetics · doi:10.1038/ng.2931 · Cited by 501
Recurrent Somatic DICER1 Mutations in Nonepithelial Ovarian Cancers
Heravi-Moussavi, A., Anglesio, M. S., Cheng, S.-W. G., Senz, J., Yang, W., Prentice, L., Fejes, A. P., Chow, C., Tone, A., Kalloger, S. E., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1102903 · Cited by 466
Self-citationA Comprehensive Analysis of PAX8 Expression in Human Epithelial Tumors
Laury, A. R., Perets, R., Piao, H., Krane, J. F., Barletta, J. A., French, C., Chirieac, L. R., Lis, R., Loda, M., Hornick, J. L., et al. (2011) · American Journal of Surgical Pathology · doi:10.1097/pas.0b013e318216c112 · Cited by 460
Sato, N., Tsunoda, H., Nishida, M., Morishita, Y., Takimoto, Y., Kubo, T., & Noguchi, M. (2000) · PubMed · doi:10.11501/3187985 · Cited by 448
Hoffman, G. R., Rahal, R., Buxton, F., Xiang, K., McAllister, G., Frias, E., Bagdasarian, L., Huber, J., Lindeman, A., Chen, D., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1316793111 · Cited by 421
Tumors of the ovary and maldeveloped gonads
Scully, R. E. (1979) · Armed Forces Institute of Pathology eBooks · Cited by 407
Ramos, P., Karnezis, A. N., Craig, D. W., Sekulic, A., Russell, M. L., Hendricks, W. P. D., Corneveaux, J. J., Barrett, M. T., Shumansky, K., Yang, Y., et al. (2014) · Nature Genetics · doi:10.1038/ng.2928 · Cited by 387
Self-citationModan, B., Hartge, P., Hirsh-Yechezkel, G., Chetrit, A., Lubin, F., Beller, U., Ben-Baruch, G., Fishman, A., Menczer, J., Struewing, J. P., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200107263450401 · Cited by 385
Recurrent SMARCA4 mutations in small cell carcinoma of the ovary
Jelinic, P., Mueller, J. J., Olvera, N., Dao, F., Scott, S. N., Shah, R., Gao, J., Schultz, N., Gonen, M., Soslow, R. A., et al. (2014) · Nature Genetics · doi:10.1038/ng.2922 · Cited by 379
Homozygous Inactivation of Sox9 Causes Complete XY Sex Reversal in Mice1
Barrionuevo, F., Bagheri-Fam, S., Klattig, J., Kist, R., Taketo, M. M., Englert, C., & Scherer, G. (2006) · Biology of Reproduction · doi:10.1095/biolreprod.105.045930 · Cited by 366
The Reduction in Risk of Ovarian Cancer Associated with Oral-Contraceptive Use
The Cancer and Steroid Hormone Study of the Centers for Disease Control and the National Institute of Child Health and Human Development* (1987) · New England Journal of Medicine · doi:10.1056/nejm198703123161102 · Cited by 365
Sanchez, A. M., Viganò, P., Somigliana, E., Panina-Bordignon, P., Vercellini, P., & Candiani, M. (2014) · Human Reproduction Update · doi:10.1093/humupd/dmt053 · Cited by 357
Ozcan, A., Shen, S. S., Hamilton, C., Anjana, K., Coffey, D., Krishnan, B., & Truong, L. D. (2011) · Modern Pathology · doi:10.1038/modpathol.2011.3 · Cited by 349
Loss of Wnt4 and Foxl2 leads to female-to-male sex reversal extending to germ cells
Ottolenghi, C., Pelosi, E., Tran, J. A., Colombino, M., Douglass, E. G., Nedorezov, T., Cao, A., Forabosco, A., & Schlessinger, D. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm235 · Cited by 340
Ovarian atypical endometriosis: its close association with malignant epithelial tumours
FUKUNAGA, M., NOMURA, K., ISHIKAWA, E., & USHIGOME, S. (1997) · Histopathology · doi:10.1046/j.1365-2559.1997.d01-592.x · Cited by 333
Colgan, T. J., Murphy, J., Cole, D. E. C., Narod, S., & Rosen, B. (2001) · The American Journal of Surgical Pathology · doi:10.1097/00000478-200110000-00009 · Cited by 327
Marquez, R. T., Baggerly, K. A., Patterson, A. P., Liu, J., Broaddus, R., Frumovitz, M., Atkinson, E. N., Smith, D. I., Hartmann, L., Fishman, D., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2509 · Cited by 308
Somigliana, E., Vigano', P., Parazzini, F., Stoppelli, S., Giambattista, E., & Vercellini, P. (2006) · Gynecologic Oncology · doi:10.1016/j.ygyno.2005.11.033 · Cited by 299
Oike, T., Ogiwara, H., Tominaga, Y., Ito, K., Ando, O., Tsuta, K., Mizukami, T., Shimada, Y., Isomura, H., Komachi, M., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-4593 · Cited by 294
Pathologic Findings in Prophylactic Oophorectomy Specimens in High-Risk Women
Leeper, K., Garcia, R., Swisher, E., Goff, B., Greer, B., & Paley, P. (2002) · Gynecologic Oncology · doi:10.1006/gyno.2002.6779 · Cited by 292
McAlpine, J. N., Hanley, G. E., Woo, M. M. M., Tone, A. A., Rozenberg, N., Swenerton, K. D., Gilks, C. B., Finlayson, S. J., Huntsman, D. G., & Miller, D. M. (2014) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2014.01.003 · Cited by 286
Self-citationOgawa, S., Kaku, T., Amada, S., Kobayashi, H., Hirakawa, T., Ariyoshi, K., Kamura, T., & Nakano, H. (2000) · Gynecologic Oncology · doi:10.1006/gyno.2000.5765 · Cited by 279
Serous Carcinogenesis in the Fallopian Tube: A Descriptive Classification
Jarboe, E., Folkins, A., Nucci, M. R., Kindelberger, D., Drapkin, R., Miron, A., Lee, Y., & Crum, C. P. (2008) · International Journal of Gynecological Pathology · doi:10.1097/pgp.0b013e31814b191f · Cited by 273
Pathology of ovarian cancer precursors
Scully, R. E. (1995) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240590928 · Cited by 264
Dubeau, L. (1999) · Gynecologic Oncology · doi:10.1006/gyno.1998.5275 · Cited by 262
Residual Complexes Containing SMARCA2 (BRM) Underlie the Oncogenic Drive of SMARCA4 (BRG1) Mutation
Wilson, B. G., Helming, K. C., Wang, X., Kim, Y., Vazquez, F., Jagani, Z., Hahn, W. C., & Roberts, C. W. M. (2014) · Molecular and Cellular Biology · doi:10.1128/mcb.01372-13 · Cited by 237
Synchronous Endometrial and Ovarian Carcinomas: Evidence of Clonality
Anglesio, M. S., Wang, Y. K., Maassen, M., Horlings, H. M., Bashashati, A., Senz, J., Mackenzie, R., Grewal, D. S., Li-Chang, H., Karnezis, A. N., et al. (2015) · Journal of the National Cancer Institute · doi:10.1093/jnci/djv428 · Cited by 229
Self-citationImmune interactions in endometriosis
Herington, J. L., Bruner-Tran, K. L., Lucas, J. A., & Osteen, K. G. (2011) · Expert Review of Clinical Immunology · doi:10.1586/eci.11.53 · Cited by 228
FOXL2 Is a Sensitive and Specific Marker for Sex Cord-Stromal Tumors of the Ovary
Al-Agha, O. M., Huwait, H. F., Chow, C., Yang, W., Senz, J., Kalloger, S. E., Huntsman, D. G., Young, R. H., & Gilks, C. B. (2011) · American Journal of Surgical Pathology · doi:10.1097/pas.0b013e31820a406c · Cited by 220
Self-citationLgr5 marks stem/progenitor cells in ovary and tubal epithelia
Ng, A., Tan, S., Singh, G., Rizk, P., Swathi, Y., Tan, T. Z., Huang, R. Y.-J., Leushacke, M., & Barker, N. (2014) · Nature Cell Biology · doi:10.1038/ncb3000 · Cited by 218
Karnezis, A. N., Wang, Y., Ramos, P., Hendricks, W. P., Oliva, E., D'Angelo, E., Prat, J., Nucci, M. R., Nielsen, T. O., Chow, C., et al. (2016) · The Journal of Pathology · doi:10.1002/path.4633 · Cited by 217
Self-citationLevanon, K., Ng, V, Piao, H. Y., Zhang, Y., Chang, M. C., Roh, M. H., Kindelberger, D. W., Hirsch, M. S., Crum, C. P., Marto, J. A., et al. (2010) · Oncogene · doi:10.1038/onc.2009.402 · Cited by 214
Pangas, S. A., Li, X., Umans, L., Zwijsen, A., Huylebroeck, D., Gutierrez, C., Wang, D., Martin, J. F., Jamin, S. P., Behringer, R. R., et al. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.01404-07 · Cited by 210
Zhao, C., Vinh, T. N., McManus, K., Dabbs, D., Barner, R., & Vang, R. (2009) · American Journal of Surgical Pathology · doi:10.1097/pas.0b013e318188373d · Cited by 207
Allelotyping of endometriosis with adjacent ovarian carcinoma reveals evidence of a common lineage.
Jiang, X., Morland, S. J., Hitchcock, A., Thomas, E. J., & Campbell, I. (1998) · PubMed · Cited by 207
Mutations of BRAF and KRAS Precede the Development of Ovarian Serous Borderline Tumors
Ho, C.-L., Kurman, R. J., Dehari, R., Wang, T.-L., & Shih, I.-M. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-2067 · Cited by 206
A quantitative assessment of oral contraceptive use and risk of ovarian cancer
Hankinson, S., Colditz, G., Hunter, D., Spencer, T., Rosner, B., & Stampfer, M. (1993) · International Journal of Gynecology & Obstetrics · doi:10.1016/0020-7292(93)90732-c · Cited by 206
Emerging roles for PAX8 in ovarian cancer and endosalpingeal development
Bowen, N. J., Logani, S., Dickerson, E. B., Kapa, L. B., Akhtar, M., Benigno, B. B., & McDonald, J. F. (2007) · Gynecologic Oncology · doi:10.1016/j.ygyno.2006.08.052 · Cited by 200
Ovarian tumors associated with atypical endometriosis
LaGrenade, A., & Silverberg, S. G. (1988) · Human Pathology · doi:10.1016/s0046-8177(88)80090-x · Cited by 195
Paik, D. Y., Janzen, D. M., Schafenacker, A. M., Velasco, V. S., Shung, M. S., Cheng, D., Huang, J., Witte, O. N., & Memarzadeh, S. (2012) · STEM CELLS · doi:10.1002/stem.1207 · Cited by 193
Prophylactic salpingectomy in premenopausal low-risk women for ovarian cancer: Primum non nocere
Morelli, M., Venturella, R., Mocciaro, R., Di Cello, A., Rania, E., Lico, D., D'Alessandro, P., & Zullo, F. (2013) · Gynecologic Oncology · doi:10.1016/j.ygyno.2013.03.023 · Cited by 193
Molecular Evidence Linking Primary Cancer of the Fallopian Tube to BRCA1 Germline Mutations
Zweemer, R. P., van Diest, P. J., Verheijen, R. H. M., Ryan, A., Gille, J. J. P., Sijmons, R. H., Jacobs, I. J., Menko, F. H., & Kenemans, P. (2000) · Gynecologic Oncology · doi:10.1006/gyno.1999.5623 · Cited by 191
Paley, P. J., Swisher, E. M., Garcia, R. L., Agoff, S. N., Greer, B. E., Peters, K. L., & Goff, B. A. (2001) · Gynecologic Oncology · doi:10.1006/gyno.2000.6071 · Cited by 189
Impact of Progestin and Estrogen Potency in Oral Contraceptives on Ovarian Cancer Risk
Schildkraut, J. M. (2002) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/94.1.32 · Cited by 185
Multifocal endometriotic lesions associated with cancer are clonal and carry a high mutation burden
Anglesio, M. S., Bashashati, A., Wang, Y. K., Senz, J., Ha, G., Yang, W., Aniba, M. R., Prentice, L. M., Farahani, H., Li Chang, H., et al. (2015) · The Journal of Pathology · doi:10.1002/path.4516 · Cited by 180
Self-citationAnglesio, M., Wang, Y., Yang, W., Senz, J., Wan, A., Heravi‐Moussavi, A., Salamanca, C., Maines‐Bandiera, S., Huntsman, D., & Morin, G. (2013) · The Journal of Pathology · doi:10.1002/path.4135 · Cited by 178
Self-citationTubal ligation and risk of ovarian cancer subtypes: a pooled analysis of case-control studies
Sieh, W., Salvador, S., McGuire, V., Weber, R. P., Terry, K. L., Rossing, M. A., Risch, H., Wu, A. H., Webb, P. M., Moysich, K., et al. (2013) · International Journal of Epidemiology · doi:10.1093/ije/dyt042 · Cited by 170
Self-citationBRCA-Mutation–Associated Fallopian Tube Carcinoma: A Distinct Clinical Phenotype?
Cass, I., Holschneider, C., Datta, N., Barbuto, D., Walts, A. E., & Karlan, B. Y. (2005) · Obstetrics & Gynecology · doi:10.1097/01.aog.0000187892.78392.3f · Cited by 166
Molecular genetic evidence that endometriosis is a precursor of ovarian cancer
Prowse, A. H., Manek, S., Varma, R., Liu, J., Godwin, A. K., Maher, E. R., Tomlinson, I. P. M., & Kennedy, S. H. (2006) · International Journal of Cancer · doi:10.1002/ijc.21845 · Cited by 164
Role of DNA Methylation and Epigenetic Silencing of HAND2 in Endometrial Cancer Development
Jones, A., Teschendorff, A. E., Li, Q., Hayward, J. D., Kannan, A., Mould, T., West, J., Zikán, M., Cibula, D., Fiegl, H., et al. (2013) · PLoS Medicine · doi:10.1371/journal.pmed.1001551 · Cited by 162
Prophylactic Salpingectomy and Delayed Oophorectomy as an Alternative for BRCA Mutation Carriers
Kwon, J. S., Tinker, A., Pansegrau, G., McAlpine, J., Housty, M., McCullum, M., & Gilks, C. B. (2013) · Obstetrics & Gynecology · doi:10.1097/aog.0b013e3182783c2f · Cited by 161
Self-citationLee, I.-H., Choi, C. H., Hong, D. G., Song, J. Y., Kim, Y. J., Kim, K. T., Lee, K. W., Park, I. S., Bae, D. S., & Kim, T. J. (2011) · Journal of Gynecologic Oncology · doi:10.3802/jgo.2011.22.3.188 · Cited by 154
Value of PAX 8 Immunostaining in Tumor Diagnosis
Ordóǹez, N. G. (2012) · Advances in Anatomic Pathology · doi:10.1097/pap.0b013e318253465d · Cited by 150
The reversible epigenetic silencing of BRM: implications for clinical targeted therapy
Glaros, S., Cirrincione, G. M., Muchardt, C., Kleer, C. G., Michael, C., & Reisman, D. (2007) · Oncogene · doi:10.1038/sj.onc.1210514 · Cited by 150
Antoniou, A. C., Rookus, M. A., Andrieu, N., Brohet, R. M., Chang-Claude, J. C., Peock, S., Cook, M., Evans, D. G., Eeles, R. A., EMBRACE, et al. (2009) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-08-0546 · Cited by 143
Hormonal factors and the risk of invasive ovarian cancer: a population-based case-control study
Pike, M. C., Pearce, C. L., Peters, R. K., Cozen, W., Wan, P. C., & Wu, A. H. (2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2004.03.013 · Cited by 139
Self-citationVercellini, P., Somigliana, E., Viganò, P., Matteis, S. D., Barbàra, G., & Fedele, L. (2010) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2010.04.018 · Cited by 135
Sherman‐Baust, C. A., Kuhn, E., Valle, B. L., Shih, I., Kurman, R. J., Wang, T., Amano, T., Ko, M. S. H., Miyoshi, I., Araki, Y., et al. (2014) · The Journal of Pathology · doi:10.1002/path.4353 · Cited by 134
Donnez, J., Casanas‐Roux, F., Caprasse, J., Ferin, J., & Thomas, K. (1985) · Fertility and Sterility · doi:10.1016/s0015-0282(16)48496-7 · Cited by 133
The Origin of Ovarian Carcinomas: A Unifying Hypothesis
Auersperg, N. (2010) · International Journal of Gynecological Pathology · doi:10.1097/pgp.0b013e3181f45f3e · Cited by 133
Serous Tubal Intraepithelial Carcinoma and the Dominant Ovarian Mass: Clues to Serous Tumor Origin?
Roh, M. H., Kindelberger, D. W., & Crum, C. P. (2009) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e3181868904 · Cited by 133
A survey of DICER1 hotspot mutations in ovarian and testicular sex cord-stromal tumors
Conlon, N., Schultheis, A. M., Piscuoglio, S., da Silva, A., Guerra, E., Tornos, C. S., Reuter, V. E., Soslow, R. A., Young, R. H., Oliva, E., et al. (2015) · Modern Pathology · doi:10.1038/modpathol.2015.115 · Cited by 133
Costs and Benefits of Opportunistic Salpingectomy as an Ovarian Cancer Prevention Strategy
Kwon, J. S., McAlpine, J. N., Hanley, G. E., Finlayson, S. J., Cohen, T., Miller, D. M., Gilks, C. B., & Huntsman, D. D. (2015) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000000630 · Cited by 132
Self-citationFoulkes, W. D., Clarke, B. A., Hasselblatt, M., Majewski, J., Albrecht, S., & McCluggage, W. G. (2014) · The Journal of Pathology · doi:10.1002/path.4362 · Cited by 125
The role of the fallopian tube in ovarian cancer.
Tone, A. A., Salvador, S., Finlayson, S. J., Tinker, A. V., Kwon, J. S., Lee, C., Cohen, T., Ehlen, T., Lee, M. H., Carey, M. S., et al. (2012) · PubMed · Cited by 123
Self-citationIncidental Nonuterine High-grade Serous Carcinomas Arise in the Fallopian Tube in Most Cases
Gilks, C. B., Irving, J., Köbel, M., Lee, C., Singh, N., Wilkinson, N. S., & McCluggage, W. G. (2014) · The American Journal of Surgical Pathology · doi:10.1097/pas.0000000000000353 · Cited by 123
Self-citationNext-Generation Sequencing of Tubal Intraepithelial Carcinomas
McDaniel, A. S., Stall, J. N., Hovelson, D. H., Cani, A. K., Liu, C., Tomlins, S. A., & Cho, K. R. (2015) · JAMA Oncology · doi:10.1001/jamaoncol.2015.1618 · Cited by 118
Self-citationTheories on the pathogenesis of endometriosis
van der Linden, P. J. Q. (1996) · Human Reproduction · doi:10.1093/humrep/11.suppl_3.53 · Cited by 117
Genetic Analysis of the Early Natural History of Epithelial Ovarian Carcinoma
Pothuri, B., Leitão, M. M., Levine, D. A., Viale, A. J., Olshen, A. B., Arroyo, C. D., Bogomolniy, F., Olvera, N., Lin, O., Soslow, R. A., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010358 · Cited by 113
Kim, J., Yoon, S., Park, M., Park, H. M., Ko, J.-J., Lee, K., & Bae, J. (2010) · Oncogene · doi:10.1038/onc.2010.541 · Cited by 113
Harmsen, M. G., Jong, M. A.-D., Hoogerbrugge, N., Maas, A. H. E. M., Prins, J. B., Bulten, J., Teerenstra, S., Adang, E., Piek, J. M. J., van Doorn, H. C., et al. (2015) · BMC Cancer · doi:10.1186/s12885-015-1597-y · Cited by 111
Ovarian Cancer is an Imported Disease: Fact or Fiction?
Kuhn, E., Kurman, R. J., & Shih, I. (2012) · Current Obstetrics and Gynecology Reports · doi:10.1007/s13669-011-0004-1 · Cited by 111
STICS SCOUTs and p53 signatures a new language for pelvic serous carcinogenesis
Crum, C. P. (2010) · Frontiers in Bioscience-Elite · doi:10.2741/e275 · Cited by 111
Edson, M. A., Nalam, R. L., Clementi, C., et al. (2010) · Molecular Endocrinology · doi:10.1210/me.2009-0461 · Cited by 109
Rare cancers: a sea of opportunity
Boyd, N., Dancey, J. E., Gilks, C. B., & Huntsman, D. D. (2016) · The Lancet Oncology · doi:10.1016/s1470-2045(15)00386-1 · Cited by 109
Self-citationBahar‐Shany, K., Brand, H., Sapoznik, S., Jacob‐Hirsch, J., Yung, Y., Korach, J., Perri, T., Cohen, Y., Hourvitz, A., & Levanon, K. (2013) · Gynecologic Oncology · doi:10.1016/j.ygyno.2013.12.015 · Cited by 107
Yamamichi, N., Yamamichi-Nishina, M., Mizutani, T., Watanabe, H., Minoguchi, S., Kobayashi, N., Kimura, S., Ito, T., Yahagi, N., Ichinose, M., et al. (2005) · Oncogene · doi:10.1038/sj.onc.1208716 · Cited by 105
Coming into focus: the nonovarian origins of ovarian cancer
Dubeau, L., & Drapkin, R. (2013) · Annals of Oncology · doi:10.1093/annonc/mdt308 · Cited by 99
Population Distribution of Lifetime Risk of Ovarian Cancer in the United States
Pearce, C. L., Stram, D. O., Ness, R. B., Stram, D. A., Roman, L. D., Templeman, C. E., Lee, A. W., Menon, U., Fasching, P. A., McAlpine, J. N., et al. (2015) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-14-1128 · Cited by 98
Self-citationEpithelial Abnormalities in Cystic Ovarian Endometriosis
Prefumo, F., Todeschini, F., Fulcheri, E., & Venturini, P. L. (2002) · Gynecologic Oncology · doi:10.1006/gyno.2001.6529 · Cited by 98
Ovary and fimbrial stem cells: biology, niche and cancer origins
Ng, A., & Barker, N. (2015) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm4056 · Cited by 94
Gonadal Development and Tumor Formation at the Crossroads of Male and Female Sex Determination
Cools, M., Wolffenbuttel, K. P., Drop, S. L. S., Oosterhuis, J. W., & Looijenga, L. H. J. (2011) · Sexual Development · doi:10.1159/000329477 · Cited by 86
Gross, A. L., Kurman, R., Vang, R., Shih, I.-M., & Visvanathan, K. (2010) · Journal of Oncology · doi:10.1155/2010/126295 · Cited by 86
Morrison, J. C., Blanco, L. Z., Vang, R., & Ronnett, B. M. (2014) · The American Journal of Surgical Pathology · doi:10.1097/pas.0000000000000352 · Cited by 84
Jelinic, P., Schlappe, B. A., Conlon, N., Tseng, J., Olvera, N., Dao, F., Mueller, J. J., Hussein, Y. R., Soslow, R. A., & Levine, D. A. (2015) · Modern Pathology · doi:10.1038/modpathol.2015.129 · Cited by 79
Auersperg, N. (2013) · International Journal of Gynecological Pathology · doi:10.1097/pgp.0b013e3182800ad5 · Cited by 77
Ovarian carcinoma arising in atypical endometriosis.
Moll, U. M., Chumas, J. C., Chalas, E., & Wj, M. (1990) · PubMed · Cited by 77
The Oncogenic Roles of DICER1 RNase IIIb Domain Mutations in Ovarian Sertoli-Leydig Cell Tumors
Wang, Y., Chen, J., Yang, W., Mo, F., Senz, J., Yap, D., Anglesio, M. S., Gilks, C. B., Morin, G. B., & Huntsman, D. D. (2015) · Neoplasia · doi:10.1016/j.neo.2015.08.003 · Cited by 76
Self-citationBanet, N., & Kurman, R. J. (2014) · International Journal of Gynecological Pathology · doi:10.1097/pgp.0000000000000120 · Cited by 76
In vitro and in vivo correlates of physiological and neoplastic human Fallopian tube stem cells
Yamamoto, Y., Ning, G., Howitt, B. E., Mehra, K. K., Wu, L., Wang, X., Yue, H., Kern, F., Wei, T. S., Zhang, T., et al. (2015) · The Journal of Pathology · doi:10.1002/path.4649 · Cited by 75
Benayoun, B. A., Caburet, S., Dipietromaria, A., Georges, A. B., D′haene, B., Pandaranayaka, E. P. J., L’Hôte, D., Todeschini, A., Krishnaswamy, S., Fellous, M., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008789 · Cited by 74
Oral contraceptive use for the primary prevention of ovarian cancer.
Havrilesky, L. J., Gierisch, J. M., Moorman, P. G., Coeytaux, R. R., Urrutia, R. P., Lowery, W. J., Dinan, M. A., McBroom, A. J., Wing, L., Musty, M. D., et al. (2013) · PubMed Central · Cited by 62
Molecular genetic analysis of ovarian serous cystadenomas
Cheng, E. J., Kurman, R. J., Wang, M., Oldt, R. J., Wang, B. G., Berman, D. M., & Shih, I. (2004) · Laboratory Investigation · doi:10.1038/labinvest.3700103 · Cited by 62
Models of endometriosis and their utility in studying progression to ovarian clear cell carcinoma
King, C. M., Barbara, C., Prentice, A., Brenton, J. D., & Jones, D. S. (2015) · The Journal of Pathology · doi:10.1002/path.4657 · Cited by 57
Singh, N., Gilks, C. B., Wilkinson, N. S., & McCluggage, W. G. (2015) · Histopathology · doi:10.1111/his.12651 · Cited by 53
Self-citationJong, M. A.-D., Harmsen, M. G., Hoogerbrugge, N., Massuger, L. F. A. G., Hermens, R., & de Hullu, J. A. (2015) · Gynecologic Oncology · doi:10.1016/j.ygyno.2014.12.031 · Cited by 49
Kalfa, N., Fellous, M., Boizet‐Bonhoure, B., Patte, C., Duvillard, P., Pienkowski, C., Jaubert, F., Ecochard, A. M., & Sultan, C. (2008) · The Journal of Urology · doi:10.1016/j.juro.2008.03.097 · Cited by 47
The silencing of the SWI/SNF subunit and anticancer gene BRM in Rhabdoid tumors
Kahali, B., Yu, J., Marquez, S. B., Thompson, K. W., Liang, S. Y., Lü, L., & Reisman, D. (2014) · Oncotarget · doi:10.18632/oncotarget.1945 · Cited by 46
Characterization of the Immune Cell Repertoire in the Normal Fallopian Tube
Ardighieri, L., Lonardi, S., Moratto, D., Facchetti, F., Shih, I., Vermi, W., & Kurman, R. J. (2014) · International Journal of Gynecological Pathology · doi:10.1097/pgp.0000000000000095 · Cited by 43
Role of Foxl2 in uterine maturation and function
Bellessort, B., Bachelot, A., Heude, É., Alfama, G., Fontaine, A., Cardinal, M. L., Treier, M., & Levi, G. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv061 · Cited by 41
Lau, A., Kollara, A., John, E. S., Tone, A. A., Virtanen, C., Greenblatt, E. M., King, W. A., & Brown, T. J. (2013) · Experimental Biology and Medicine · doi:10.1177/1535370213508216 · Cited by 33
DICER1 RNase IIIb domain mutations are infrequent in testicular germ cell tumours
de Boer, C. M., Eini, R., Gillis, A., Stoop, H., Looijenga, L. H. J., & White, S. J. (2012) · BMC Research Notes · doi:10.1186/1756-0500-5-569 · Cited by 24
GDF9 Modulates the Reproductive and Tumor Phenotype of Female Inha-Null Mice1
Myers, M., Mansouri-Attia, N., James, R., Jia, P., & Pangas, S. A. (2013) · Biology of Reproduction · doi:10.1095/biolreprod.112.104125 · Cited by 17
Heart and Neural Crest Derivatives Expressed Transcript 2 (HAND2)
Buell‐Gutbrod, R., Cavallo, A., Lee, N. K., MONTAG, A. G., & Gwin, K. (2014) · International Journal of Gynecological Pathology · doi:10.1097/pgp.0000000000000106 · Cited by 17
Cited by
High-Grade Serous Ovarian Cancer: Basic Sciences, Clinical and Therapeutic Standpoints
Lisio, M.-A., Fu, L., Goyeneche, A., Gao, Z.-H., & Telleria, C. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20040952 · Cited by 680
Caruso, G., Weroha, S. J., & Cliby, W. (2025) · JAMA · doi:10.1001/jama.2025.9495 · Cited by 304
Cell Origins of High-Grade Serous Ovarian Cancer
Kim, J., Park, E., Kim, O., Schilder, J., Coffey, D., Cho, C.-H., & Bast, R. (2018) · Cancers · doi:10.3390/cancers10110433 · Cited by 264
Hallas-Potts, A., Dawson, J. C., & Herrington, C. S. (2019) · Scientific Reports · doi:10.1038/s41598-019-41941-4 · Cited by 110
Metadata
- Authors
- Karnezis, A. N., Cho, K. R., Gilks, C. B., Pearce, C. L., & Huntsman, D. G.
- Venue
- Nature Reviews Cancer
- Published
- 2016-11-25
- Volume
- 17
- Issue
- 1
- Pages
- 65-74
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2555058267
- Cited by
- 300
- References
- 128
- FWCI
- 5.47
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.